Locations
San Carlos, CA, USA · Durham, NC, USA
industry
Biotechnology
Size
1 - 10 employees
Stage
Seed
founded in
2016
Celldom is developing next generation, high throughput single cell analysis technology to advance research, drug discovery, and drug development by illuminating diversity in cell populations. The company's Clonexplorer and proprietary nanowell plates uniquely integrate both phenotypic and genomic data at massive scale (up to 100,000s of cells per experiment) to identify and characterize rare cells that play critical roles in biological pathways and disease. Celldom is developing initial applications of the platform in the areas of oncology, immunology, and stem cell biology. Learn more at www.celldom.com and follow the company's growth @celldominc on Twitter.
Something looks off?